1.02 (-%)
As of Nov 22, 2024
Source:
Cue Biopharma, Inc is a clinical-stage biopharmaceutical company engineering a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient’s body.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | (617) 949-2680 |
Industry | manufacturing |
CEO | Daniel R. Passeri |
Website | www.cuebiopharma.com |